Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 19 studies | 81% ± 17% | |
oligodendrocyte | 16 studies | 71% ± 19% | |
oligodendrocyte precursor cell | 16 studies | 77% ± 26% | |
GABAergic neuron | 10 studies | 76% ± 23% | |
endothelial cell | 10 studies | 38% ± 18% | |
ciliated cell | 9 studies | 30% ± 9% | |
microglial cell | 8 studies | 41% ± 21% | |
glutamatergic neuron | 7 studies | 53% ± 23% | |
interneuron | 6 studies | 72% ± 25% | |
cardiac muscle cell | 6 studies | 69% ± 17% | |
mesothelial cell | 6 studies | 47% ± 22% | |
kidney distal convoluted tubule epithelial cell | 5 studies | 53% ± 37% | |
neuron | 5 studies | 42% ± 15% | |
epithelial cell | 5 studies | 23% ± 6% | |
kidney loop of Henle epithelial cell | 5 studies | 57% ± 35% | |
club cell | 5 studies | 53% ± 19% | |
type I pneumocyte | 5 studies | 22% ± 5% | |
type II pneumocyte | 5 studies | 76% ± 10% | |
granule cell | 4 studies | 69% ± 18% | |
Mueller cell | 4 studies | 32% ± 8% | |
smooth muscle cell | 4 studies | 32% ± 7% | |
macrophage | 3 studies | 31% ± 10% | |
GABAergic interneuron | 3 studies | 67% ± 32% | |
glial cell | 3 studies | 32% ± 10% | |
GABAergic amacrine cell | 3 studies | 41% ± 10% | |
glycinergic amacrine cell | 3 studies | 25% ± 3% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 29% ± 5% | |
adipocyte | 3 studies | 42% ± 10% | |
retinal pigment epithelial cell | 3 studies | 40% ± 5% | |
ependymal cell | 3 studies | 61% ± 25% | |
respiratory goblet cell | 3 studies | 41% ± 21% | |
fibroblast | 3 studies | 37% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2603.63 | 2639 / 2642 | 87% | 12.23 | 613 / 705 |
breast | 60% | 935.35 | 274 / 459 | 75% | 15.58 | 838 / 1118 |
thymus | 93% | 590.77 | 607 / 653 | 33% | 1.54 | 200 / 605 |
kidney | 97% | 1387.82 | 86 / 89 | 13% | 1.10 | 114 / 901 |
blood vessel | 94% | 1240.01 | 1260 / 1335 | 0% | 0 | 0 / 0 |
ovary | 4% | 13.91 | 8 / 180 | 80% | 8.61 | 346 / 430 |
heart | 83% | 713.84 | 711 / 861 | 0% | 0 | 0 / 0 |
muscle | 63% | 301.63 | 507 / 803 | 0% | 0 | 0 / 0 |
lung | 51% | 328.35 | 296 / 578 | 6% | 0.33 | 75 / 1155 |
uterus | 5% | 151.51 | 9 / 170 | 17% | 1.25 | 77 / 459 |
adrenal gland | 3% | 13.91 | 8 / 258 | 17% | 1.22 | 40 / 230 |
stomach | 19% | 64.03 | 69 / 359 | 0% | 0.08 | 1 / 286 |
pancreas | 16% | 55.08 | 53 / 328 | 3% | 0.23 | 5 / 178 |
adipose | 13% | 49.17 | 154 / 1204 | 0% | 0 | 0 / 0 |
skin | 8% | 25.89 | 140 / 1809 | 3% | 0.19 | 13 / 472 |
bladder | 5% | 11.90 | 1 / 21 | 3% | 0.12 | 17 / 504 |
prostate | 2% | 10.19 | 6 / 245 | 2% | 0.06 | 11 / 502 |
eye | 0% | 0 | 0 / 0 | 4% | 0.11 | 3 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 1.56 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.11 | 1 / 45 |
esophagus | 0% | 1.44 | 6 / 1445 | 1% | 0.06 | 2 / 183 |
liver | 0% | 0 | 0 / 226 | 1% | 0.03 | 3 / 406 |
intestine | 0% | 0.48 | 1 / 966 | 0% | 0.01 | 2 / 527 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0001755 | Biological process | neural crest cell migration |
GO_0007507 | Biological process | heart development |
GO_0060045 | Biological process | positive regulation of cardiac muscle cell proliferation |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0007165 | Biological process | signal transduction |
GO_0007275 | Biological process | multicellular organism development |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0060749 | Biological process | mammary gland alveolus development |
GO_0061026 | Biological process | cardiac muscle tissue regeneration |
GO_2000010 | Biological process | positive regulation of protein localization to cell surface |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0043653 | Biological process | mitochondrial fragmentation involved in apoptotic process |
GO_0038138 | Biological process | ERBB4-ERBB4 signaling pathway |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0009880 | Biological process | embryonic pattern specification |
GO_0022008 | Biological process | neurogenesis |
GO_0045165 | Biological process | cell fate commitment |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030334 | Biological process | regulation of cell migration |
GO_0060644 | Biological process | mammary gland epithelial cell differentiation |
GO_0021889 | Biological process | olfactory bulb interneuron differentiation |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0072046 | Biological process | establishment of planar polarity involved in nephron morphogenesis |
GO_0007595 | Biological process | lactation |
GO_0038135 | Biological process | ERBB2-ERBB4 signaling pathway |
GO_0007416 | Biological process | synapse assembly |
GO_0007399 | Biological process | nervous system development |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0021551 | Biological process | central nervous system morphogenesis |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0099645 | Biological process | neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0016477 | Biological process | cell migration |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0038130 | Biological process | ERBB4 signaling pathway |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005006 | Molecular function | epidermal growth factor receptor activity |
GO_0038131 | Molecular function | neuregulin receptor activity |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0050811 | Molecular function | GABA receptor binding |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ERBB4 |
Protein name | Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] Erb-b2 receptor tyrosine kinase 4 receptor protein-tyrosine kinase (EC 2.7.10.1) Alternative protein ERBB4 Uncharacterized protein ERBB4 ERBB4 transcript variant I12DEL ERBB4 transcript variant I20DEL |
Synonyms | HER4 |
Description | FUNCTION: Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins and EGF family members and regulates development of the heart, the central nervous system and the mammary gland, gene transcription, cell proliferation, differentiation, migration and apoptosis. Required for normal cardiac muscle differentiation during embryonic development, and for postnatal cardiomyocyte proliferation. Required for normal development of the embryonic central nervous system, especially for normal neural crest cell migration and normal axon guidance. Required for mammary gland differentiation, induction of milk proteins and lactation. Acts as cell-surface receptor for the neuregulins NRG1, NRG2, NRG3 and NRG4 and the EGF family members BTC, EREG and HBEGF. Ligand binding triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Ligand specificity and signaling is modulated by alternative splicing, proteolytic processing, and by the formation of heterodimers with other ERBB family members, thereby creating multiple combinations of intracellular phosphotyrosines that trigger ligand- and context-specific cellular responses. Mediates phosphorylation of SHC1 and activation of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Isoform JM-A CYT-1 and isoform JM-B CYT-1 phosphorylate PIK3R1, leading to the activation of phosphatidylinositol 3-kinase and AKT1 and protect cells against apoptosis. Isoform JM-A CYT-1 and isoform JM-B CYT-1 mediate reorganization of the actin cytoskeleton and promote cell migration in response to NRG1. Isoform JM-A CYT-2 and isoform JM-B CYT-2 lack the phosphotyrosine that mediates interaction with PIK3R1, and hence do not phosphorylate PIK3R1, do not protect cells against apoptosis, and do not promote reorganization of the actin cytoskeleton and cell migration. Proteolytic processing of isoform JM-A CYT-1 and isoform JM-A CYT-2 gives rise to the corresponding soluble intracellular domains (4ICD) that translocate to the nucleus, promote nuclear import of STAT5A, activation of STAT5A, mammary epithelium differentiation, cell proliferation and activation of gene expression. The ERBB4 soluble intracellular domains (4ICD) colocalize with STAT5A at the CSN2 promoter to regulate transcription of milk proteins during lactation. The ERBB4 soluble intracellular domains can also translocate to mitochondria and promote apoptosis. . |
Accessions | A0A0P0IT07 ENST00000260943.11 Q53QS8 L8E872 Q4ZG14 Q53T57 A0A0P0I3A3 E9PDR1 ENST00000342788.9 [Q15303-1] H3BLT0 ENST00000260943.11 [Q15303-4] Q15303 ENST00000436443.5 [Q15303-3] ENST00000435846.1 Q53R48 Q580Q7 Q53R25 |